How should upatinib be discontinued?

Upadacitinib is a selective JAK1 inhibitor that is widely used to treat immune-mediated diseases such as rheumatoid arthritis and atopic dermatitis. During treatment, it may sometimes be necessary to adjust or stop the medication based on the progression of the condition or other medical factors. However, as an immunomodulatory drug, discontinuation of upadatinib needs to be done with caution to avoid adverse reactions or disease recurrence.

When using upadatinib, sudden discontinuation may cause a rebound or worsening of symptoms, especially for patients with more severe conditions. Therefore, a gradual reduction in dosage is usually recommended. This means that when you decide to stop taking a drug, you should gradually reduce the dose of the drug based on your doctor's advice rather than stopping it completely immediately. Gradually reducing the dose allows the body to adapt to changes in drug concentration and reduces discomfort.

Each patient's condition and body's response to medications is different, so discontinuation plans should be tailored to individual circumstances. Patients must communicate with their primary care physician before deciding to discontinue upadacitinib. The doctor will recommend whether it is appropriate to reduce the dosage or discontinue the medication based on the patient's symptoms, treatment effects, and disease stability, and formulate a specific discontinuation plan. Following professional advice is key to ensuring safe and effective withdrawal.

During the withdrawal process, patients need to closely observe changes in their symptoms, especially whether there are signs of recurrence, such as worsening of joint pain, resurgence of skin symptoms, etc. If it is found that the condition has a tendency to recur during the withdrawal of medication, the doctor should be notified immediately so that the treatment plan can be adjusted in a timely manner. In some cases, it may be necessary to restart the medication or switch to another treatment.

After stopping the drug, patients still need to maintain good living habits and health management, including appropriate exercise, a reasonable diet, and regular medical examinations. Keeping the immune system stable helps reduce the risk of disease recurrence and maintains the effectiveness of treatment.